Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.

MLA

Peggs, Karl S., et al. “Reduced-Intensity Transplantation with in Vivo T-Cell Depletion and Adjuvant Dose-Escalating Donor Lymphocyte Infusions for Chemotherapy-Sensitive Myeloma: Limited Efficacy of Graft-versus-Tumor Activity.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 9, no. 4, Apr. 2003, pp. 257–65. EBSCOhost, https://doi.org/10.1053/bbmt.2003.50009.

APA

Peggs, K. S., Mackinnon, S., Williams, C. D., D’Sa, S., Thuraisundaram, D., Kyriakou, C., Morris, E. C., Hale, G., Waldmann, H., Linch, D. C., Goldstone, A. H., & Yong, K. (2003). Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 9(4), 257–265. https://doi.org/10.1053/bbmt.2003.50009

Chicago

Peggs, Karl S, Stephen Mackinnon, Catherine D Williams, Shirley D’Sa, Dharsha Thuraisundaram, Charalampia Kyriakou, Emma C Morris, et al. 2003. “Reduced-Intensity Transplantation with in Vivo T-Cell Depletion and Adjuvant Dose-Escalating Donor Lymphocyte Infusions for Chemotherapy-Sensitive Myeloma: Limited Efficacy of Graft-versus-Tumor Activity.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 9 (4): 257–65. doi:10.1053/bbmt.2003.50009.